Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.

@article{Piechotta2020ConvalescentPO,
  title={Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.},
  author={V. Piechotta and K. L. Chai and Sarah J Valk and C. Doree and I. Monsef and E. Wood and A. Lamikanra and C. Kimber and Z. McQuilten and C. So-Osman and L. Estcourt and Nicole Skoetz},
  journal={The Cochrane database of systematic reviews},
  year={2020},
  volume={7},
  pages={
          CD013600
        }
}
  • V. Piechotta, K. L. Chai, +9 authors Nicole Skoetz
  • Published 2020
  • Medicine
  • The Cochrane database of systematic reviews
  • BACKGROUND Convalescent plasma and hyperimmune immunoglobulin may reduce mortality in patients with viral respiratory diseases, and are currently being investigated in trials as potential therapy for coronavirus disease 2019 (COVID-19). A thorough understanding of the current body of evidence regarding the benefits and risks is required.  OBJECTIVES: To continually assess, as more evidence becomes available, whether convalescent plasma or hyperimmune immunoglobulin transfusion is effective and… CONTINUE READING
    Convalescent plasma for patients with severe COVID-19: a matched cohort study
    1
    COVID 19 : State of the Art of Antiviral Management
    • WM AgüeroEcheverría, P andMartínez
    • 2020